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Abstract
Background:  A procedure for including activity against enveloped viruses in the post-
contamination treatment of hands has been recommended, but so far no European standard is
available to implement it. In 2004, the German Robert Koch-Institute (RKI) and the German
Association for the Control of Virus Disease (DVV) suggested that vaccinia virus and bovine viral
diarrhea virus (BVDV) should be used as test viruses in a quantitative suspension test to determine
the activity of a disinfectant against all enveloped viruses.
Methods: We have studied the activities of three commonly-used alcohol-based hand rubs (hand
rub A, based on 45% propan-2-ol, 30% propan-1-ol and 0.2% mecetronium etilsulfate; hand rub B,
based on 80% ethanol; hand rub C, based on 95% ethanol) against vaccinia virus and BVDV, and in
addition against four other clinically relevant enveloped viruses: herpes simplex virus (HSV) types
1 and 2, and human and avian influenza A virus. The hand rubs were challenged with different
organic loads at exposure time of 15, 30 and 60 s. According to the guidelines of both BGA/RKI
and DVV, and EN 14476:2005, the reduction of infectivity of each test virus was measured on
appropriate cell lines using a quantitative suspension test.
Results: All three alcohol-based hand rubs reduced the infectivity of vaccinia virus and BVDV by
≥ 4 log10-steps within 15 s, irrespective of the type of organic load. Similar reductions of infectivity
were seen against the other four enveloped viruses within 15 s in the presence of different types
of organic load.
Conclusion: Commonly used alcohol-based hand rubs with a total alcohol concentration ≥ 75%
can be assumed to be active against clinically relevant enveloped viruses if they effectively reduce
the infectivities of vaccinia virus and BVDV in a quantitative suspension test.
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Background
During the past few years, many healthcare workers have
changed from antimicrobial liquid soaps to alcohol-based
hand rubs for the post-contamination treatment of hands,
as suggested by the CDC guideline for hand hygiene [1].
The two main reasons are broader and faster efficacy,
which is beneficial in preventing cross-transmission of
nosocomial pathogens [2,3], and superior dermal toler-
ance, which is beneficial for compliance with hand
hygiene regulations [3,4]. Recently it has been suggested
that a preparation for routine hand hygiene should be
active at least against bacteria, yeasts and enveloped
viruses [3]. This minimum spectrum of activity is based on
data on the contamination of healthcare workers' hands,
on the transmissibility of nosocomial pathogens, and on
outbreaks of nosocomial infections caused by contami-
nated hands of healthcare workers [3]. Quantitative sus-
pension tests are used to determine the spectrum of
activity [5]. Recommendations for use in the hospital are
usually derived from efficacy tests under practical condi-
tions [5]. Bactericidal activity can be determined accord-
ing to prEN 13727 (formerly prEN 12054) [6]. It has been
shown using a propanol-based hand rub that the four test
bacteria of this test norm cover the whole spectrum of
nosocomial bacterial strains and clinical isolates includ-
ing emerging pathogens [7]. For fungicidal activity, only a
basic test (EN 1275) is available [8]. One of the two test
fungi for EN 1275 is Candida albicans, which may serve as
the clinically relevant test strain for determining activity
against yeasts. To determine virucidal activity, EN
14476:2005 should be used [9]. However, this European
norm is only designed for determining "complete viru-
cidal activity", which for hand disinfection includes only
two non-enveloped viruses: adenovirus type 5 and polio-
virus type 1. No European norm is available for determin-
ing activity specific against enveloped viruses, although a
national test method has recently been published by the
German Association for the Control of Virus Disease
(DVV) and the Robert Koch-Institute (RKI) [10]. Such a
test norm at the European level would certainly be desira-
ble. The RKI has recently used the phrase "limited viru-
cidal activity" ("active against enveloped viruses such as
HIV, HBV, and HCV") to describe a preparation that has
proven active against two representative enveloped
viruses, vaccinia virus and bovine viral diarrhea virus
(BVDV) [11]. BVDV serves as a model for Hepatitis C
Virus (HCV) because this pestivirus also belongs to the
family Flaviviridae and has some properties similar to
HCV [12-14].
To date, however, there is no evidence to show that the
two chosen test viruses cover other clinically relevant
enveloped viruses in respect of stability against disinfect-
ants. That is why we have tested the activities of three dif-
ferent alcohol-based hand rubs against the two suggested
test viruses, and in addition against four other enveloped
viruses that represent some of the most relevant or
recently-emerging enveloped viruses in human medicine.
Methods
Test preparations
The following alcohol-based hand rubs were tested: Prep-
aration A, based on isopropanol (45%, w/w), n-propanol
(30%, w/w) and mecetronium etilsulfate (0.2%, w/w);
preparation B, based on ethanol (80%, w/w); and prepa-
ration C, based on ethanol (95%, w/w). All hand rubs
were manufactured by Bode Chemie GmbH & Co. KG,
Hamburg, Germany.
Test viruses
Virus suspensions that allowed a reduction of at least 4
log10-steps to be measured were used in all experiments.
Infectivity assays were performed between 2003 and 2006
according to the test method of the Bundesgesundheit-
samt (BGA, Federal Office of Health, now Robert Koch-
Institute) and the German Association for the Control of
Virus Disease (DVV) [15], which uses the same test princi-
ple as EN 14476, with the following test viruses:
• Vaccinia virus strain Elstree, passaged and cultured in
buffalo green monkey cells (BGM cells) (range of virus
titres: 7.6–9.9 log10TCID50/ml)
• Bovine viral diarrhea virus (BVDV) strain NADL, ATCC
VR-534, passaged and cultured in KOP-R cells (range of
virus titres: 5.5–6.4 log10TCID50/ml)
• Herpes simplex virus (HSV) type 1 MacIntyre, ATCC VR-
539, passaged and cultured in Vero cells (African green
monkey kidney, ATCC CCL-81) (range of virus titres: 7.5–
8.1 log10TCID50/ml)
• Herpes simplex virus type 2, ATCC VR-540, passaged
and cultured in Vero cells (range of virus titres: 7.6–8.5
log10TCID50/ml)
• Human influenza A virus, Panama strain 2007/99
(H3N2), passaged and cultured in Madin-Darby canine
kidney epithelial cells (range of virus titres: 5.5–5.9
log10TCID50/ml)
• Avian influenza A virus/duck/Ukraine/1/63 (H3N8),
passaged and cultured in Madin-Darby canine kidney epi-
thelial cells (range of virus titres: 6.5–6.9 log10TCID50/
ml). This virus was used as surrogate for H5N1 owing to
biosafety considerations.
Inactivation assay
Tests were conducted in accordance with BGA/RKI and
DVV guidelines in a waterbath at 20°C [15]. Eight parts byBMC Infectious Diseases 2007, 7:5 http://www.biomedcentral.com/1471-2334/7/5
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volume of the disinfectant were mixed with one part by
volume of the virus suspension and one part by volume of
aqua bidest. This test mixture was investigated at exposure
times of 15, 30 and 60 seconds. In tests with different
organic loads, one part by volume of the interfering sub-
stance was added instead of aqua bidest. The disinfectant
was inactivated immediately at the end of the chosen
exposure time by serial dilution with ice-cold cell culture
medium or by gel filtration with MicroSpin™ S-400 HR
columns (Amersham Biosciences Europe GmbH, 79021
Freiburg, Germany), which were used according to the
manufacturer's instructions, to reduce the cytotoxicity of
the product when BVDV or either of the influenza viruses
was tested. Virus controls without columns were run in
parallel.
Owing to the addition of virus suspension and organic
load, disinfectants could only be evaluated as 80% solu-
tions.
Virus controls were incorporated after the longest expo-
sure time (60 s). One part by volume of virus suspension
was mixed with nine parts by volume of aqua bidest. or
with one part by volume of organic load and eight parts
by volume of aqua bidest.
One experiment was performed for each hand rub, each
exposure time, each virus and each type of organic load.
Types of organic load
Different types of organic load were used (final concentra-
tions):
▪ No organic load (aqua bidest.)
▪10% fetal calf serum
▪ 0.2% bovine serum albumin
▪ 0.03% bovine serum albumin ("clean conditions"
according to EN 14476:2005)
▪ 0.3% bovine serum albumin with 0.3% washed sheep
erythrocytes ("dirty conditions" according to EN
14476:2005).
Determination of cytotoxicity
To determine the cytotoxicity of the disinfectants, two
parts by volume of aqua bidest. were mixed with eight
parts by volume of the disinfectant, diluted with ice-cold
cell culture medium and inoculated into permissive cells.
Controls for the different organic loads consisted of one
part by volume of aqua bidest, one part by volume of
organic load and eight parts by volume of the disinfectant.
Any microscopic changes in the cells were recorded when
the tests were read for cytopathic effects (CPE). This con-
trol allowed cytotoxicity and viral CPE to be clearly differ-
entiated.
Determination of infectivity
Infectivity was determined in a micro-procedure by end-
point dilution titration. At the end of each exposure time,
the test mixture was immediately diluted with ice-cold cell
culture medium, and 100 µl of each dilution were placed
in 8 wells of a sterile polystyrene flat-bottomed 96-well
microtitre plate (Nunc A/S, 4000 Roskilde, Denmark)
with a preformed cell culture monolayer. The microtitre
plates were incubated at 37°C with 5% CO2 for the appro-
priate incubation time (3–10 days). Cultures were
observed for the presence or absence of CPE. The infective
dose (TCID50) was calculated according to the method of
Spearman [16] and Kärber [17]. Titre reduction was calcu-
lated as the difference between the virus titres of the water
control (60 s) and the products after the contact times,
and is presented as the reduction factor (RF). The follow-
ing formula was used:
RF = a - b
a = log10 TCID50/ml of the control titration
b = log10 TCID50/ml of the test virus titration (after hand
rub exposure)
A reduction of infectivity of ≥ 4 log10-steps (inactivation ≥
99.99%) was regarded as evidence of sufficient virucidal
activity against the tested virus according German and
European guidelines [15].
Results
The cytotoxicity of the hand rubs was 2 log10-steps in all
cell lines. Only hand rub C was toxic to MDCK cells at
1:1000 dilution.
All three alcohol-based hand rubs reduced the infectivity
of vaccinia virus and BVDV by ≥ 4 log10-steps within 15 s,
irrespective of the type of organic load (Table 1). Similar
reduction factors were seen within 15 s against the other
four enveloped viruses (HSV type 1 and 2; human and
avian influenza A virus) with or without organic load
(Table 1).
Discussion
Limited data have been published on the spectrum of
virucidal activity of alcohol-based hand rubs [18,19]. In
particular, HBV has been described as an enveloped virus
that may be less easy to inactivate [19,20].
By testing three commonly-used alcohol-based hand rubs
containing at least 75% alcohol, we were able to showB
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Table 1: Reduction of viral infectivity (log10 steps) obtained with three alcohol-based hand rubs (A: based on 45% isopropanol, 30% n-propanol and 0.2% mecetronium etilsulfate; B: based 
on 80% ethanol; C: based on 95% ethanol) against the six different enveloped viruses with different types of organic load.
Hand rub Type of organic load* BVDV Vaccinia virus HSV 1 HSV 2 Human influenza A virus Avian influenza A virus
reduction of viral infectivity (log10-steps) within a defined contact time**
15 s 30 s 60 s 15 s 30 s 60 s 15 s 30 s 60 s 15 s 30 s 60 s 15 s 30 s 60 s 15 s 30 s 60 s
AN o n e ≥ 4.3 ≥ 6.3 ≥ 4.0 ≥ 4.8 ≥ 4.3 ≥ 5.1
10% FCS ≥ 4.3 ≥ 5.3 ≥ 4.3 ≥ 4.8 ≥ 4.4 ≥ 5.3
0.2% BSA ≥ 4.8 ≥ 5.6 ≥ 4.0 ≥ 5.0 ≥ 4.3 ≥ 5.3
"clean conditions" ≥ 4.7 ≥ 5.7 ≥ 4.4 ≥ 4.1 ≥ 4.4 ≥ 5.0
"dirty conditions" ≥ 4.5 ≥ 6.4 ≥ 4.4 ≥ 4.1 ≥ 4.0 ≥ 5.4
BN o n e ≥ 4.3 ≥ 5.0 ≥ 4.4 ≥ 4.4 ≥ 4.3 ≥ 5.1
10% FCS ≥ 4.0 ≥ 5.3 ≥ 4.4 ≥ 4.4 ≥ 4.4 ≥ 5.3
0.2% BSA ≥ 4.0 ≥ 5.3 ≥ 4.4 ≥ 4.4 ≥ 4.3 ≥ 5.3
"clean conditions" ≥ 4.0 ≥ 5.0 ≥ 4.6 ≥ 4.5 ≥ 4.4 ≥ 5.0
"dirty conditions" ≥ 4.2 ≥ 5.4 ≥ 4.5 ≥ 4.6 ≥ 4.0 ≥ 5.4
CN o n e ≥ 4.4 ≥ 4.8 ≥ 4.3 ≥ 4.4 ≥ 4.3 ≥ 5.1
10% FCS ≥ 4.5 ≥ 4.5 ≥ 4.3 ≥ 4.4 ≥ 4.4 ≥ 5.3
0.2% BSA ≥ 4.9 ≥ 4.1 ≥ 4.0 ≥ 4.4 ≥ 4.3 ≥ 5.3
"clean conditions" ≥ 4.9 ≥ 4.5 ≥ 4.4 ≥ 4.0 ≥ 4.4 ≥ 5.0
"dirty conditions" ≥ 4.7 ≥ 5.5 ≥ 4.0 ≥ 4.4 ≥ 4.0 ≥ 5.4
*FCS: 10% fetal calf serum; BSA: 0.2% bovine serum albumin; "clean conditions": (0.03% bovine serum albumin); "dirty conditions": (0.3% bovine serum albumin and 0.3% sheep erythrocytes) **one result is 
presented in which the log10 reduction was the same at all three exposure timesBMC Infectious Diseases 2007, 7:5 http://www.biomedcentral.com/1471-2334/7/5
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that the data obtained with vaccinia virus and BVDV indi-
cated that the preparations are also active against other
enveloped viruses relevant to human medicine. According
to the declaration of the RKI and DVV the preparations
have "limited virucidal activity" and can be considered
active against all enveloped viruses relevant to human
medicine. "Activity" is the common term in Europe to
describe the spectrum of activity in quantitative suspen-
sion tests ("in vitro"), whereas "efficacy" is used to
describe the effect measured in experiments under practi-
cal conditions ("in vivo"). Suspension tests are important
for determining the spectrum of activity. Nevertheless,
better recommendations can be derived from experiments
under practical conditions (phase 2, step 2 tests) such as
the ASTM method E-1838-02 [21]. However, some of the
above-mentioned viruses cannot be tested on human
hands for reasons of biosafety. Furthermore, the type of
organic load might strongly influence the virucidal effi-
cacy on hands [22].
All hand rubs were tested at exposure times of 15, 30 and
60 s. The 30 s exposure time best resembles the practical
use of hand rubs in hygienic hand disinfection. All the
hand rubs tested have a total alcohol concentration of
75% or more. It would also have been interesting to study
alcohol-based hand rubs with a lower alcohol concentra-
tion to verify the data in a more challenging experimental
setting. However, hand rubs with 70% alcohol or less
have been shown to have only limited bactericidal activity
and should therefore not be used in hospitals [23,24].
Thus, it did not seem to be clinically relevant to verify the
activity of such hand rubs against enveloped viruses.
We also found that all the types of organic loads tested in
these experiments hardly impaired the activities of the
hand rubs against the different enveloped viruses. It has
previously been shown using feline calicivirus that the
type of organic load may significantly influence the mean
reduction of viral infectivity in a test under practical con-
ditions [22]. That is why it seemed crucial to confirm
activity not only against different viral species but also
under various types of organic load. The real bioburden
on healthcare workers' hands, however, may consist of
blood, pus, serum, sebum, triglycerides, surface active
agents and carbohydrates [25]. The greatest reduction of
activity has been reported with blood [25]. It has also
been found that the bactericidal efficacy of alcohol-based
hand rubs is not significantly impaired if hands are con-
taminated with 1.2 ml blood [26]. On the basis of our
data and the results from Larson and Bobo [24], it is
unlikely that the presence of blood would significantly
impair the activity of alcohol-based hand rubs against
enveloped viruses. For clinical practice it is recommended
to use alcohol-based hand rubs if hands are not visibly
soiled [1]. Whenever hands are visibly dirty or visibly
soiled a hand wash should be performed [1]. That is why
our results with rather low quantities of organic load sup-
port the confidence into the activity of the tested hand
rubs against enveloped viruses when the hand rubs are
used as recommended on clean hands.
Viral infectivity was reduced to below the limit of detec-
tion in all experiments at 15 s (which is half as long as the
current clinical application time for hand rubs) irrespec-
tive of the viral species, the type and amount of organic
load, and the type of hand rub. It is technically almost
impossible to evaluate application times shorter than 15 s
in such a test because the disinfectant activity is termi-
nated by immediate dilution. Moreover, it would have
only limited clinical relevance, since a single application
of an alcohol-based hand rub usually ensures a contact
time of 25–30 s before the alcohol is evaporated [24].
Activity against both test viruses in a quantitative suspen-
sion test does of course not include the inactivation of
non-enveloped viruses in vitro. Entero-, rota-, adeno- and
noroviruses e.g. are in general more resistant than BVDV
and vaccinia virus. A virucidal activity (effectiveness
against all viruses) of a hand disinfectant is difficult to
achieve requiring normally a high concentration of etha-
nol [3] or some kind of synergistic effect. In many situa-
tions in medical settings an activity against enveloped
viruses is sufficient for a hand rub [3]. On wards with
recurrent viral infections or during outbreaks caused by
non-enveloped viruses, a hand disinfectant with virucidal
activity is absolutely necessary to interrupt the transmis-
sion of viruses by human hands.
Conclusion
Overall, commonly-used alcohol-based hand rubs with
75% alcohol or more can be assumed to be active against
clinically relevant enveloped viruses if they reduce the
infectivities of vaccinia virus and BVDV in the presence of
different standard organic loads by ≥ 4 log10-steps. It will
be important to confirm our results with selected envel-
oped viruses including surrogate viruses applying test
methods using the finger pads or the whole hand of vol-
unteers.
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